BPC-157 vs GHK-Cu

BPC-157 is believed to accelerate angiogenesis and upregulate growth hormone receptors locally at injury sites. It appears to promote fibroblast migration and collagen synthesis, contributing to faster tissue remodelling. Animal studies suggest systemic effects via modulation of the dopaminergic and serotonergic systems, though human data remain limited.

BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It is commonly researched for its role in soft tissue repair, particularly in tendons, ligaments, and muscle following injury or high training loads. Early research suggests it may also support gut integrity and systemic healing.

GHK-Cu promotes the synthesis of collagen, elastin, glycosaminoglycans, and decorin, contributing to tissue remodelling and wound contraction. It modulates the activity of matrix metalloproteinases (MMPs) — stimulating wound-healing MMPs while suppressing those that degrade healthy tissue. Genomic analysis has identified GHK-Cu as a modulator of over 4,000 genes, including those governing antioxidant defences and anti-inflammatory pathways.

GHK-Cu (copper peptide tripeptide-1) is a naturally occurring plasma copper complex with broad tissue-remodelling activity. It is one of the most extensively researched peptides for skin health, wound healing, and collagen synthesis. Research has explored its effects across dermatological, cosmetic, and systemic contexts, including roles in joint tissue maintenance and anti-inflammatory signalling.